{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT04336254",
      "OrgStudyIdInfo": {
        "OrgStudyId": "2020K-G005"
      },
      "SecondaryIdInfoList": {
        "SecondaryIdInfo": [
          {
            "SecondaryId": "hDPSC-CoVID-2019-02-2020",
            "SecondaryIdType": "Other Identifier",
            "SecondaryIdDomain": "Renmin Hospital of Wuhan University"
          }
        ]
      },
      "Organization": {
        "OrgFullName": "Renmin Hospital of Wuhan University",
        "OrgClass": "OTHER"
      },
      "BriefTitle": "Safety and Efficacy Study of Allogeneic Human Dental Pulp Mesenchymal Stem Cells to Treat Severe COVID-19 Patients",
      "OfficialTitle": "Safety and Efficacy Study of Allogeneic Human Dental Pulp Mesenchymal Stem Cells to Treat Severe Pneumonia of COVID-19：a Single-center, Prospective, Randomised Clinical Trial"
    },
    "StatusModule": {
      "StatusVerifiedDate": "March 2021",
      "OverallStatus": "Recruiting",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "May 6, 2020",
        "StartDateType": "Actual"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "November 30, 2021",
        "PrimaryCompletionDateType": "Anticipated"
      },
      "CompletionDateStruct": {
        "CompletionDate": "December 31, 2021",
        "CompletionDateType": "Anticipated"
      },
      "StudyFirstSubmitDate": "March 28, 2020",
      "StudyFirstSubmitQCDate": "April 3, 2020",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "April 7, 2020",
        "StudyFirstPostDateType": "Actual"
      },
      "LastUpdateSubmitDate": "March 8, 2021",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "March 10, 2021",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Principal Investigator",
        "ResponsiblePartyInvestigatorFullName": "Ye Qingsong",
        "ResponsiblePartyInvestigatorTitle": "Professor, Director",
        "ResponsiblePartyInvestigatorAffiliation": "Renmin Hospital of Wuhan University"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Renmin Hospital of Wuhan University",
        "LeadSponsorClass": "OTHER"
      },
      "CollaboratorList": {
        "Collaborator": [
          {
            "CollaboratorName": "Beijing SH Bio-Tech Corporation, Beijing (CN)",
            "CollaboratorClass": "UNKNOWN"
          },
          {
            "CollaboratorName": "Utooth Biological Technology Co., Ltd. Hubei (CN)",
            "CollaboratorClass": "UNKNOWN"
          }
        ]
      }
    },
    "OversightModule": {
      "OversightHasDMC": "Yes",
      "IsFDARegulatedDrug": "No",
      "IsFDARegulatedDevice": "No"
    },
    "DescriptionModule": {
      "BriefSummary": "This clinical trial is set out to evaluate the safety and efficacy of allogeneic human dental pulp mesenchymal stem cells in the treatment of severe pneumonia caused by COVID-19; to explore the effects of human dental pulp mesenchymal stem cells in the treatment of severe pneumonia of COVID-19 in terms of reducing mortality and improving clinical prognosis; and to discover a new therapeutic strategy for COVID-19 using allogeneic human dental pulp mesenchymal stem cells.",
      "DetailedDescription": "This clinical trial is set out to evaluate the followings:\n\nthe safety and efficacy of allogeneic human dental pulp mesenchymal stem cells in the treatment of severe pneumonia caused by COVID-19;\nto explore the effects of human dental pulp mesenchymal stem cells in the treatment of severe pneumonia of COVID-19 in terms of reducing mortality and improving clinical prognosis; and\nto discover a new therapeutic strategy for COVID-19 using allogeneic human dental pulp mesenchymal stem cells."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "COVID-19"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "Cronovirus",
          "Human Dental Pulp Stem Cells",
          "Dental Stem Cell Banking"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 1",
          "Phase 2"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "Randomized",
        "DesignInterventionModel": "Parallel Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "Triple",
          "DesignWhoMaskedList": {
            "DesignWhoMasked": [
              "Participant",
              "Investigator",
              "Outcomes Assessor"
            ]
          }
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "20",
        "EnrollmentType": "Anticipated"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "hDPSCs group",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "Routine treatment + Intravenous injection of human dental pulp stem cells",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: allogeneic human dental pulp stem cells (BSH BTC & Utooth BTC)"
              ]
            }
          },
          {
            "ArmGroupLabel": "Control group",
            "ArmGroupType": "Placebo Comparator",
            "ArmGroupDescription": "Routine treatment + Intravenous saline injection (Placebo)",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Other: Intravenous saline injection (Placebo)"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Biological",
            "InterventionName": "allogeneic human dental pulp stem cells (BSH BTC & Utooth BTC)",
            "InterventionDescription": "Intravenous injection of 3.0x10e7 human dental pulp stem cells solution (30ml) on day 1, day 4 and day 7, based on routine treatment of COVID-19",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "hDPSCs group"
              ]
            }
          },
          {
            "InterventionType": "Other",
            "InterventionName": "Intravenous saline injection (Placebo)",
            "InterventionDescription": "Intravenous injection of 3ml of 0.9% saline on day 1, day 4 and day 7, based on routine treatment of COVID-19",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Control group"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "TTCI",
            "PrimaryOutcomeDescription": "Time to Clinical Improvement",
            "PrimaryOutcomeTimeFrame": "1-28 days"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "Lung lesion",
            "SecondaryOutcomeDescription": "Lung Lesion by CT",
            "SecondaryOutcomeTimeFrame": "1-28 days"
          },
          {
            "SecondaryOutcomeMeasure": "Immune function",
            "SecondaryOutcomeDescription": "Th1 cytokines: IL-1β, IL- 2, TNF-a, ITN-γ;\nTh2 cytokines: IL- 4, IL- 6, IL- 10;\nImmunoglobulins: IgA, IgG, IgM, and total IgE;\nLymphocyte counts: CD3+, CD4+, CD8+, CD16+,CD19+, CD56+.",
            "SecondaryOutcomeTimeFrame": "1-28 days"
          },
          {
            "SecondaryOutcomeMeasure": "Time of SARS-CoV-2 clearance",
            "SecondaryOutcomeDescription": "Time of SARS-CoV-2 test turns negative",
            "SecondaryOutcomeTimeFrame": "1-28 days"
          },
          {
            "SecondaryOutcomeMeasure": "Blood test",
            "SecondaryOutcomeDescription": "Blood cell count and classification",
            "SecondaryOutcomeTimeFrame": "1-28 days"
          },
          {
            "SecondaryOutcomeMeasure": "SPO2",
            "SecondaryOutcomeDescription": "Pulse oximetry",
            "SecondaryOutcomeTimeFrame": "1-28 days"
          },
          {
            "SecondaryOutcomeMeasure": "RR",
            "SecondaryOutcomeDescription": "Respiratory rate",
            "SecondaryOutcomeTimeFrame": "1-28 days"
          },
          {
            "SecondaryOutcomeMeasure": "Body temperature",
            "SecondaryOutcomeDescription": "Body temperature",
            "SecondaryOutcomeTimeFrame": "1-28 days"
          },
          {
            "SecondaryOutcomeMeasure": "Side effects in the treatment group",
            "SecondaryOutcomeDescription": "Number of the included patients with hDPSCs-related adverse events, e.g. liver or kidney function failure",
            "SecondaryOutcomeTimeFrame": "1-28 days"
          },
          {
            "SecondaryOutcomeMeasure": "C-reactive protein (mg/L)",
            "SecondaryOutcomeDescription": "C-reactive protein in microgram per litre",
            "SecondaryOutcomeTimeFrame": "1-28 days"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nAged 18-65 years;\nVoluntarily participate in this clinical trial and sign off \"informed consent form\";\nDiagnosed with severe pneumonia of COVID: respiratory distress, RR >30 times / min; resting oxygen saturation of 93% or less; arterial partial pressure of oxygen / oxygen concentration 300mmHg; SARS-CoV-2 nucleic acid test was positive.\nChest imaging confirm COVID-19 featured lesions in lung.\n\nExclusion Criteria:\n\nReceive any clinical trial drug treatment for COVID-2019 within 30 days before the screening assessment;\nSevere liver disease (e.g., Child Pugh score >=C or AST> 5 times of the upper limit);\nPatients with known severe renal insufficiency (estimated glomerular filtration rate <=30mL / min/1.73 m2) or patients receiving continuous renal replacement therapy, hemodialysis, peritoneal dialysis;\nCo-infection of HIV, hepatitis B, tuberculosis, influenza virus, adenovirus or other respiratory infection viruses;\nFemale patients who have no sexual protection in the last 30 days prior to the screening assessment;\nPregnant or lactating women or women using estrogen contraception;\nPatients who are planning to become pregnant during the study period or within 6 months after the end of the study period;\nOther conditions that the researchers consider not suitable for participating in this clinical trial.",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "18 Years",
      "MaximumAge": "65 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult",
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "CentralContactList": {
        "CentralContact": [
          {
            "CentralContactName": "Qingsong Ye, PhD,DDS",
            "CentralContactRole": "Contact",
            "CentralContactPhone": "+8615858242516",
            "CentralContactEMail": "qingsongye@foxmail.com"
          },
          {
            "CentralContactName": "Chenliang Zhou, PhD",
            "CentralContactRole": "Contact",
            "CentralContactPhone": "+862788041919",
            "CentralContactPhoneExt": "83920"
          }
        ]
      },
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Prof. Qingsong Ye, PhD,DDS",
            "OverallOfficialAffiliation": "Center for Regenerative Medicine, Renmin Hospital of Wuhan University",
            "OverallOfficialRole": "Study Chair"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "Renmin Hospital of Wuhan University (East Campus)",
            "LocationStatus": "Recruiting",
            "LocationCity": "Wuhan",
            "LocationState": "Hubei",
            "LocationCountry": "China",
            "LocationContactList": {
              "LocationContact": [
                {
                  "LocationContactName": "Chenliang Zhou, PhD",
                  "LocationContactRole": "Contact",
                  "LocationContactPhone": "+86 027 88041919",
                  "LocationContactPhoneExt": "83920"
                }
              ]
            }
          }
        ]
      }
    },
    "ReferencesModule": {
      "ReferenceList": {
        "Reference": [
          {
            "ReferencePMID": "32532356",
            "ReferenceType": "derived",
            "ReferenceCitation": "Ye Q, Wang H, Xia X, Zhou C, Liu Z, Xia ZE, Zhang Z, Zhao Y, Yehenala J, Wang S, Zhou G, Hu K, Wu B, Wu CT, Wang S, He Y. Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I / II). Trials. 2020 Jun 12;21(1):520. doi: 10.1186/s13063-020-04380-5."
          }
        ]
      }
    },
    "IPDSharingStatementModule": {
      "IPDSharing": "No"
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000086382",
            "ConditionMeshTerm": "COVID-19"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000012141",
            "ConditionAncestorTerm": "Respiratory Tract Infections"
          },
          {
            "ConditionAncestorId": "D000007239",
            "ConditionAncestorTerm": "Infections"
          },
          {
            "ConditionAncestorId": "D000011024",
            "ConditionAncestorTerm": "Pneumonia, Viral"
          },
          {
            "ConditionAncestorId": "D000011014",
            "ConditionAncestorTerm": "Pneumonia"
          },
          {
            "ConditionAncestorId": "D000014777",
            "ConditionAncestorTerm": "Virus Diseases"
          },
          {
            "ConditionAncestorId": "D000018352",
            "ConditionAncestorTerm": "Coronavirus Infections"
          },
          {
            "ConditionAncestorId": "D000003333",
            "ConditionAncestorTerm": "Coronaviridae Infections"
          },
          {
            "ConditionAncestorId": "D000030341",
            "ConditionAncestorTerm": "Nidovirales Infections"
          },
          {
            "ConditionAncestorId": "D000012327",
            "ConditionAncestorTerm": "RNA Virus Infections"
          },
          {
            "ConditionAncestorId": "D000008171",
            "ConditionAncestorTerm": "Lung Diseases"
          },
          {
            "ConditionAncestorId": "D000012140",
            "ConditionAncestorTerm": "Respiratory Tract Diseases"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M2562",
            "ConditionBrowseLeafName": "COVID-19",
            "ConditionBrowseLeafAsFound": "COVID-19",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M13056",
            "ConditionBrowseLeafName": "Pneumonia",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M9435",
            "ConditionBrowseLeafName": "Infections",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M5520",
            "ConditionBrowseLeafName": "Communicable Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M14130",
            "ConditionBrowseLeafName": "Respiratory Tract Infections",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M13066",
            "ConditionBrowseLeafName": "Pneumonia, Viral",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M16674",
            "ConditionBrowseLeafName": "Virus Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M19643",
            "ConditionBrowseLeafName": "Coronavirus Infections",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M5707",
            "ConditionBrowseLeafName": "Coronaviridae Infections",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M22838",
            "ConditionBrowseLeafName": "Nidovirales Infections",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M14301",
            "ConditionBrowseLeafName": "RNA Virus Infections",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M10320",
            "ConditionBrowseLeafName": "Lung Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M14129",
            "ConditionBrowseLeafName": "Respiratory Tract Diseases",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC01",
            "ConditionBrowseBranchName": "Infections"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC08",
            "ConditionBrowseBranchName": "Respiratory Tract (Lung and Bronchial) Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC23",
            "ConditionBrowseBranchName": "Symptoms and General Pathology"
          }
        ]
      }
    },
    "InterventionBrowseModule": {
      "InterventionBrowseLeafList": {
        "InterventionBrowseLeaf": [
          {
            "InterventionBrowseLeafId": "M21013",
            "InterventionBrowseLeafName": "Pharmaceutical Solutions",
            "InterventionBrowseLeafRelevance": "low"
          }
        ]
      },
      "InterventionBrowseBranchList": {
        "InterventionBrowseBranch": [
          {
            "InterventionBrowseBranchAbbrev": "PhSol",
            "InterventionBrowseBranchName": "Pharmaceutical Solutions"
          },
          {
            "InterventionBrowseBranchAbbrev": "All",
            "InterventionBrowseBranchName": "All Drugs and Chemicals"
          }
        ]
      }
    }
  }
}